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Cone/usion:This study of a large number of Ml pta ?80 yra suggeats that
pts at higher risk for one year mortality are Iesa likely to undergo post Ml
catheterization, while male pts, those with recurrent aymptoms and with prior
interventions are more likely to undergo cath. Presentation to a hospital in
New England haa a strong negative association with oath compared to the
rest of the country.
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n7775 Post-Ml testing in the elderly: Results in 190,135petients
E.D. Peterson, J.G. Jollis, J.A. Stafford, E.R. DeLong, L.H. Muhlbaier,
L.J. Shaw, D.B. Mark. Duke University Medical CerrteLDurham, NC, USA
National guidelines have suggested that post-Ml risk stratification should
include an aesesament of underlying mronary disease (CAD) severity and
left ventricular function. It ia unclear, however, whether these guidelines are
followed in the elderly. Uaing National Medicare Date (Parl A and B files),
we examined the use of non-invasive atreas tests (NIST), echocardiography
(Echo) and catheterization (Cath) during the first 80 daya following Ml in
190,135 patients aged ?65 admitted between 1/92 and 11/92.The median
age was 78.8 yre, 50.4% were women. Overall 30-day mortality rate was
21.2%, ranging from 12% in thoae 85-S9 yre to 47% for those ?80 yrs. At
Ieaat one NIST waa performed in 22% of patients, 54% had Echo and 35%
underwent Cath. Asseaament of CAD risk (Cath or NIST) occurred in 44%
and 68% had a quantitative measurement of LVEF (Echo, Cath or MUGA).
Patterns of post-Ml care by age group are displayed below:
Age Group(n) NIST Echo Cath Assess CAD Risk Measure LVEF
(“A) (“’4) (“/0) (%) (“A)
65-69 (37,994) 36 54 57 69 79
70-74 (44,398) 29 55 47 59 75
75-79 (42,459) 22 56 35 46 69
?80 (65,286) 10 51 12 19 57
Cone/usion:Despitefacin9 high post-Ml mortality risks,the use of invasive
and noninvasive teating for post-Ml risk stratification declined markedly with
advancing patient age. In particular, a LVEF waa flOt measured in over 40%
of octogenarian while over 80% had no formal assessment of CAD risk.
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myocerdial perfusion SPECT in the very elderly
A.M. Amanullah, R. Hachamovitch, J. Erel, J. Friedman, H. Lewin,
D.S. Berman. Cedara-Sinai Medicai Ctc L.A., CA, USA
Little ia known regarding the enhanced risk stratification of the very elderly
using myocardial perfusion imaging. Thua, we studied 873 consecutive pta
age ?80 years who underwent dual isotope myocerdial perfusion SPECT
(DIMPS) (rest T1-201/stressTc-99m sestamibi). 49 pts were Ioat to foliow-
UP(F/U) and 58 pta had early revascularizatiofl (S w days after DIMPS).
The remaining 766 pte (age: 83+3 years; exercise IEx~adenosine [Aden]:
381/405) were F/U for at least 1 year (mean 20+8 months) for hard events
(HE) [cardiac death (CD) or non-fatal Ml]. DIMPS was visually assessed
using 20 SPECT aegmente and a 5 point acoring system (O= normal, 4 =
absent uptake) from which aummed streas score (SSS), summed rest score
(SRS) and aummad reversibility or difference (SDS) score were calculated.
At F/U 83 HE occurred (Ex: CD = 17, nonfatal Ml = 12; Aden: CD = 43,
nonfatal Ml = 11). HE rates in Ex were 8% compared to 13% for Aden (p <
0.02). HE rates in pte with normal or mildly abnormal (SSS ? 8) scans were
4% (9/228) in Ex and 5% (11/215) in Aden, compared to 14.8% (20/135) in
Ex and 22.6% (4W190) in Aden for pts with severely abnormal scans (SSS
< 8) (p <0.001 for both). By a stepwise Cox proportional hazards model of
prescan variables, age and,exercise duration yielded aignificent information
(% = 5.4 and% = 18.7) in Ex, and age and history of Ml in Aden (~ =
6.6 and % = 7.3). For Ex, SDS added significant futther information after
“forcing in” the prescan variables (% = 39.4, gain in ~, p c 0.001). For
Aden, SSS added incremental information (% = 38.4, gain in J@,p < 0.001).
Conclusions: Among pts age ?80 yeare with an overall high HE rate, Ex
or Aden DIMPS added significant incremental prognostic information over
clinical, historical and physiologic variables.
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~] Clini~alSignifi~an~eof ~eurological Events
Associated with Carotid Stenting
S.S. Iyer, G. Roubin, S. Yadav,A. Mathur, C. Gomez, J.M. Parks, G. Yates,
K. Kretzer,J, Vitek. The University of A/abarna at Birmingham, Birmingham,
AL, USA
To determine the clinical significance of neurological events associated with
carotid stenting the prospectively recorded procedure complications in a
consecutive seriea of patients undergoing protocol conforming percutaneous
(femoral approach) carotid stent placement procedures were analyzed. One
off protocol death, one past procedure contralateral cardiogenic embolic
stroke and TIA’s were excluded. Between 9/94 and 8/96, 180 pts underwent
carotid atenting using both balloon expandable (BE), (95 pte, 111 veasels)
and self expanding (SE) (85 pts, 101 vessela). Definitions of neurological
events using change in NIH Stroke Scale and time to resolution together with
occurrence of these events are shown below.
Minimsl Neuro Deficit Minor Stroke Major Stroke
NIH Stroke Sale Chamae o-1 2-3 or ?4&
Deficit Resolution (days~ 57 530 >30
111 vessels with BE stents 5 2 1
101 vessels with SE stents 3 4 0
Total: 212 vessels 8 (3.80/’) 6 (2.8”/0) 1 (0.4%)
Two of six patients with minor strokes returned to baaeline within seven
days.
Conclusion: The incidence of neurological events following carotid stent-
ing ia acceptably low. Approximately half the events are minimal deficits, the
majority resolve within seven days.
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After Carotid Stent-Supported Angioplasty in
High-Risk Patients
JR. Laird, L.F.Satler, J.J. Popma, G.S. Mintz, A.J. Lensky, K. Horton,
S. Cabellon, R. Deible, R. Mehran, N. Prunka, M.B. Leon. Washington
Hospital Centec Washington, DC, USA
Catheter-based therapies for the treatment of extra-cranial carotid artery
diaease may be especially appropriate in patients who are at high risk for
complications from carotid endarterectomy (CEA). We performed 32 carotid
stent-supported angioplasty (CSSA) procedures in 30 patients with balloon
expandable tubular slotted stents. High risk patient characteristics included
significant coronary artery disease in 777., left ventricular dysfunction (LVEF
c 45%) in 30%, age >60 in 17%, and other co-morbid conditions (prior
CEA, COPD, A Fib, etc.) in 37%. Procedural success was achieved in
31 (97%) procedures. There was one procedural failure due to aortic arch
tortuosity. Quantitative angiography was performed using standard edge
detection techniques.
Baseline Final
Distal reference (mm) 4.62 + 0.89 4.82 & 0.80
Minimal lumen diameter (mm) 1.72 + 0.69 4,42 & 0.79
% Diameter stenosia ‘ 63& 14 8*12
There were no major angiographic complications. A proximal edge dis-
section occurred in one case (3%) requiring additional stenta. Two patients
(6%) experienced aperi-procedural minor atroke with resolution of symptoms
within one week. There were no procedure related deaths, M1’aor major
atrokes. One patient (3%) died within 30 days from an unrelated cause.
In conclusion: early experience with CSSA in high-risk patients is favor-
able with high technical/angiographic success and infrequent early clinical
events.
